Safety and Efficacy of Percutaneous Morton Neuroma Cryoneurolysis Under Ultrasound Guidance.

Cryoneurolysis Metatarsalgia Morton neuroma Ultrasound guidance

Journal

Cardiovascular and interventional radiology
ISSN: 1432-086X
Titre abrégé: Cardiovasc Intervent Radiol
Pays: United States
ID NLM: 8003538

Informations de publication

Date de publication:
04 Mar 2024
Historique:
received: 12 09 2023
accepted: 20 01 2024
medline: 5 3 2024
pubmed: 5 3 2024
entrez: 4 3 2024
Statut: aheadofprint

Résumé

To assess the technical success, safety and early efficacy of Morton neuroma (MN) cryoneurolysis. Retrospective review of 54 consecutive patients with MN treated with cryoneurolysis after failure of conservative treatment, from September 2022 to June 2023. Outcomes measurements included technical success (defined a successful ultrasound-guided placement of the cryoprobe), procedural safety according to Cirse classification and change in 6 months post-procedure by pain numeric rating scale (pNRS). A total of 59 MN were treated during 55 procedures. Mean procedure duration was 47 min, all patients were discharged 2 h after the intervention. Technical success was 98.1%. No Cirse grade 3, 4 or 5 complication was reported. Three grade 2 complication occurred, including two chilblain-type lesions and one bone insufficiency fracture. At 6 months post-procedure, pNRS score was significantly decreased (2.7 ± 2.2 vs 7.1 ± 1.1) (p < 0.0001), with a mean score decrease of 4.1points. Thirty-two patients (60.4%) reported a complete pain relief, 15 (28.3%) a partial pain relief and 6 (11.3%) no pain relief, or increased pain. Cryoneurolysis seems to be safe for the treatment of Morton neuroma. Six-month pain relief is promising and needs to be confirmed at long term.

Identifiants

DOI: 10.1007/s00270-024-03669-1 PMID: 38438685
pubmed: 38438685
doi: 10.1007/s00270-024-03669-1
pii: 10.1007/s00270-024-03669-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).

Références

Hodes A, Umans H. Metatarsalgia. Radiol Clin North Am. 2018;56:877–92. https://doi.org/10.1016/j.rcl.2018.06.004 .
doi: 10.1016/j.rcl.2018.06.004 pubmed: 30322488
Bhatia M, Thomson L. Morton’s neuroma–current concepts review. Journal of Clinical Orthopaedics and Trauma. 2020;11:406–9. https://doi.org/10.1016/j.jcot.2020.03.024 .
doi: 10.1016/j.jcot.2020.03.024 pubmed: 32405199 pmcid: 7211826
Hau MYT, Thomson L, Aujla R, et al. Medium-term results of corticosteroid injections for Morton’s neuroma. Foot Ankle Int. 2021;42:464–8. https://doi.org/10.1177/1071100720966332 .
doi: 10.1177/1071100720966332 pubmed: 33106028
Womack JW, Richardson DR, Murphy GA, et al. Long-term evaluation of interdigital neuroma treated by surgical excision. Foot Ankle Int. 2008;29:574–7. https://doi.org/10.3113/FAI.2008.0574 .
doi: 10.3113/FAI.2008.0574 pubmed: 18549752
Gurdezi S, White T, Ramesh P. Alcohol injection for Morton’s neuroma: a five-year follow-up. Foot Ankle Int. 2013;34:1064–7. https://doi.org/10.1177/1071100713489555 .
doi: 10.1177/1071100713489555 pubmed: 23669161
Chuter GSJ, Chua YP, Connell DA, Blackney MC. Ultrasound-guided radiofrequency ablation in the management of interdigital (Morton’s) neuroma. Skeletal Radiol. 2013;42:107–11. https://doi.org/10.1007/s00256-012-1527-x .
doi: 10.1007/s00256-012-1527-x pubmed: 23073898
Cazzato RL, Garnon J, Ramamurthy N, et al. Percutaneous MR-guided cryoablation of Morton’s neuroma: rationale and technical details after the first 20 patients. Cardiovasc Intervent Radiol. 2016;39:1491–8. https://doi.org/10.1007/s00270-016-1365-7 .
doi: 10.1007/s00270-016-1365-7 pubmed: 27189181
Ilfeld BM, Finneran JJ. Cryoneurolysis and percutaneous peripheral nerve stimulation to treat acute pain. Anesthesiology. 2020;133:1127–49. https://doi.org/10.1097/ALN.0000000000003532 .
doi: 10.1097/ALN.0000000000003532 pubmed: 32898231
Filippiadis DK, Binkert C, Pellerin O, et al. Cirse quality assurance document and standards for classification of complications: the Cirse classification system. Cardiovasc Intervent Radiol. 2017;40:1141–6. https://doi.org/10.1007/s00270-017-1703-4 .
doi: 10.1007/s00270-017-1703-4 pubmed: 28584945
Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8. https://doi.org/10.1038/bmt.2012.244 .
doi: 10.1038/bmt.2012.244 pubmed: 23208313
Caporusso EF, Fallat LM, Savoy-Moore R. Cryogenic neuroablation for the treatment of lower extremity neuromas. J Foot Ankle Surg. 2002;41:286–90. https://doi.org/10.1016/S1067-2516(02)80046-1 .
doi: 10.1016/S1067-2516(02)80046-1 pubmed: 12400711
Friedman T, Richman D, Adler R. Sonographically guided Cryoneurolysis: preliminary experience and clinical outcomes. J Ultrasound Med. 2012;31:2025–34. https://doi.org/10.7863/jum.2012.31.12.2025 .
doi: 10.7863/jum.2012.31.12.2025 pubmed: 23197557
Kasparek M, Schneider W. Surgical treatment of Morton’s neuroma: clinical results after open excision. International Orthopaedics (SICOT). 2013;37:1857–61. https://doi.org/10.1007/s00264-013-2002-6 .
doi: 10.1007/s00264-013-2002-6
Deniz S, Purtuloglu T, Tekindur S, et al. Ultrasound-guided pulsed radio frequency treatment in Morton’s neuroma. J Am Podiatr Med Assoc. 2015;105:302–6. https://doi.org/10.7547/13-128.1 .
doi: 10.7547/13-128.1 pubmed: 25945935
Masala S, Cuzzolino A, Morini M, et al. Ultrasound-guided percutaneous radiofrequency for the treatment of Morton’s neuroma. Cardiovasc Intervent Radiol. 2018;41:137–44. https://doi.org/10.1007/s00270-017-1786-y .
doi: 10.1007/s00270-017-1786-y pubmed: 28956110
Hughes RJ, Ali K, Jones H, et al. Treatment of Morton’s neuroma with alcohol injection under sonographic guidance: follow-up of 101 cases. Am J Roentgenol. 2007;188:1535–9. https://doi.org/10.2214/AJR.06.1463 .
doi: 10.2214/AJR.06.1463
Bucknall V, Rutherford D, MacDonald D, et al. Outcomes following excision of Morton’s interdigital neuroma: a prospective study. The Bone & Joint Journal. 2016;98:1376–81. https://doi.org/10.1302/0301-620X.98B10.37610 .
doi: 10.1302/0301-620X.98B10.37610
Coughlin MJ, Pinsonneault T. Operative treatment of interdigital neuroma. A long-term follow-up study. J Bone Joint Surg Am. 2001;83:1321–8.
doi: 10.2106/00004623-200109000-00005 pubmed: 11568193
Faraj AA, Hosur A. The outcome after using two different approaches for excision of Morton’s neuroma. Chin Med J (Engl). 2010;123:2195–8.
pubmed: 20819664
Giannini S, Bacchini P, Ceccarelli F, Vannini F. Interdigital neuroma: clinical examination and histopathologic results in 63 cases treated with excision. Foot Ankle Int. 2004;25:79–84. https://doi.org/10.1177/107110070402500208 .
doi: 10.1177/107110070402500208 pubmed: 14992707
Nery C, Raduan F, Del Buono A, et al. Plantar approach for excision of a Morton neuroma: a long-term follow-up study. J Bone Joint Surg. 2012;94:654–8. https://doi.org/10.2106/JBJS.K.00122 .
doi: 10.2106/JBJS.K.00122 pubmed: 22488622
Pace A, Scammell B, Dhar S. The outcome of Morton’s neurectomy in the treatment of metatarsalgia. International Orthopaedics (SICOT). 2010;34:511–5. https://doi.org/10.1007/s00264-009-0812-3 .
doi: 10.1007/s00264-009-0812-3

Auteurs

Benjamin Moulin (B)

From the Interventional Radiology Unit, Imaging Department (B.M., G.A., J.L.S., O.V., M.D.P., A.H.), From the Orthopedic Surgery Unit (S.R), and From the Anesthesiology Department (TG), American Hospital of Paris, 55 Boulevard du Chateau, 92200, Neuilly-sur-Seine, France. b.moulin00@gmail.com.
ORCID: 0000-0002-5195-3085

Giorgio Angelopoulos (G)

From the Interventional Radiology Unit, Imaging Department (B.M., G.A., J.L.S., O.V., M.D.P., A.H.), From the Orthopedic Surgery Unit (S.R), and From the Anesthesiology Department (TG), American Hospital of Paris, 55 Boulevard du Chateau, 92200, Neuilly-sur-Seine, France.

Jean Luc Sarrazin (JL)

From the Interventional Radiology Unit, Imaging Department (B.M., G.A., J.L.S., O.V., M.D.P., A.H.), From the Orthopedic Surgery Unit (S.R), and From the Anesthesiology Department (TG), American Hospital of Paris, 55 Boulevard du Chateau, 92200, Neuilly-sur-Seine, France.

Stephane Romano (S)

From the Interventional Radiology Unit, Imaging Department (B.M., G.A., J.L.S., O.V., M.D.P., A.H.), From the Orthopedic Surgery Unit (S.R), and From the Anesthesiology Department (TG), American Hospital of Paris, 55 Boulevard du Chateau, 92200, Neuilly-sur-Seine, France.

Olivier Vignaux (O)

From the Interventional Radiology Unit, Imaging Department (B.M., G.A., J.L.S., O.V., M.D.P., A.H.), From the Orthopedic Surgery Unit (S.R), and From the Anesthesiology Department (TG), American Hospital of Paris, 55 Boulevard du Chateau, 92200, Neuilly-sur-Seine, France.

Thierry Guenoun (T)

From the Interventional Radiology Unit, Imaging Department (B.M., G.A., J.L.S., O.V., M.D.P., A.H.), From the Orthopedic Surgery Unit (S.R), and From the Anesthesiology Department (TG), American Hospital of Paris, 55 Boulevard du Chateau, 92200, Neuilly-sur-Seine, France.

Massimiliano Di Primio (M)

From the Interventional Radiology Unit, Imaging Department (B.M., G.A., J.L.S., O.V., M.D.P., A.H.), From the Orthopedic Surgery Unit (S.R), and From the Anesthesiology Department (TG), American Hospital of Paris, 55 Boulevard du Chateau, 92200, Neuilly-sur-Seine, France.

Antoine Hakime (A)

From the Interventional Radiology Unit, Imaging Department (B.M., G.A., J.L.S., O.V., M.D.P., A.H.), From the Orthopedic Surgery Unit (S.R), and From the Anesthesiology Department (TG), American Hospital of Paris, 55 Boulevard du Chateau, 92200, Neuilly-sur-Seine, France.

Classifications MeSH